The Effect of a Psychosomatic Symptom Intervention Program on the Primary Treatment of Differentiated Thyroid Cancer

Clinical trial NCT06422702 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06422702
Sponsor: Harbin Medical University
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Pathologically Confirmed Differentiated Thyroid Carcinoma All Patients Are in the Initial Treatment Phase Normal Cognitive and Communicative Abilities, Capable of Reading and Understanding Questionnaires in Chinese Ability to Use a Smartphone Voluntary Participation in the Study and Signed Informed Consent

Start date: 2023-08-01
Primary completion: 2024-01-22
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.